2-iodomelatonin has been researched along with 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate in 1 studies
Studies (2-iodomelatonin) | Trials (2-iodomelatonin) | Recent Studies (post-2010) (2-iodomelatonin) | Studies (3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate) | Trials (3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate) | Recent Studies (post-2010) (3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate) |
---|---|---|---|---|---|
245 | 0 | 10 | 774 | 2 | 59 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Niles, LP; Ying, SW | 1 |
1 other study(ies) available for 2-iodomelatonin and 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate
Article | Year |
---|---|
3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate-solubilized binding sites for 2-[125I]iodomelatonin in chick brain retain sensitivity to guanine nucleotides.
Topics: Animals; Binding Sites; Brain; Cell Membrane; Chickens; Cholic Acids; Cytosol; Detergents; Guanine Nucleotides; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Iodine Radioisotopes; Kinetics; Male; Melatonin; Receptors, Melatonin; Receptors, Neurotransmitter; Solubility | 1991 |